跳至主要内容
临床试验/ACTRN12619001398190
ACTRN12619001398190已完成未知

The clinical and microbiome outcomes of medical treatments in chronic rhinosinusitis: a double-blinded, randomised placebo-controlled trial

Associate Professor Psaltis0 个研究点目标入组 50 人开始时间: 2019年10月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Selection/inclusion criteria:
  • Patients who meet ALL of the following criteria will be offered inclusion in the study:
  • (1)Have symptoms and signs of CRS and require medical management AND
  • (2)are over 18 years of age AND
  • (3)are able to give written informed consent AND
  • (4)are local patients who will be returning to this centre for follow-up care

排除标准

  • (1)Requirement for a specific corticosteroid or antibiotic treatment based on symptomatology
  • (2)allergy to steroids
  • (3)pregnant or breastfeeding
  • (4)diabetes
  • (5)on other CYP450 inhibiting drugs (e.g. ketoconazole, ritonavir, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir and telithromycin)
  • (6)liver disease

研究者

发起方
Associate Professor Psaltis

相似试验

Effects of topical and oral corticosteroids on... | 临床试验